Merck's Pepcid
Executive Summary
H2 receptor-antagonist product approved by FDA for short-term treatment of gastric ulcer. Pepcid (famotidine) is already approved for short-term treatment of active duodenal ulcers and as maintenance therapy for duodenal ulcer patients at reduced doses after healing of an active ulcer....